Unique ID issued by UMIN | UMIN000041854 |
---|---|
Receipt number | R000047778 |
Scientific Title | Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients |
Date of disclosure of the study information | 2020/09/21 |
Last modified on | 2023/04/09 19:21:35 |
Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients
Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients
Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients
Efficacy and safety of prehospital administration of tranexamic acid (TXA) for trauma patients
Japan |
Trauma
Emergency medicine | Intensive care medicine |
Others
NO
To establish a treatment for trauma patients by early TXA administration, we will administer TXA to trauma patients transported by the doctor car or the helicopter in prehospital settings, and confirm the efficacy and safety of TXA administration based on the clinical course and outcome of the patients. In addition, we will examine the efficacy of TXA administration in prehospital settings based on the changes in coagulation fibrinolytic parameters and elucidate the pathogenesis of coagulation fibrinolytic disorders associated with trauma.
Safety,Efficacy
Mortality at 28 days
mRS at 3 months, volume of transfusion, coagulation fibrinolytic parameters (prothrombin time (PT), activated partial thromboplastin time (aPTT), Fibrinogen, thrombin-antithrombin complex (TAT), FDP, D-dimer, alpha 2 plasmin inhibitor (alpha 2-PI), plasmin-alpha 2 plasmin inhibitor complex (PIC), plasminogen activator inhibitor 1 (PAI-1), t-PA-PAI-1 complex)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
Administer 1 g of TXA intravenously in prehospital settings.
18 | years-old | <= |
Not applicable |
Male and Female
1. Patients over the age of 18 years.
2. Trauma patients who are transported by the doctor car or the helicopter to Nippon Medical School Hospital, Nippon Medical School Musashikosugi Hospital, Nippon Medical School Tama-Nagayama Hospital, or Nippon Medical School Chiba Hokuso Hospital.
3. Patients who are able to receive TXA in prehospital settings within 3 hours of the injury.
1. Patients with a history of hypersensitivity to TXA
2. Patients with diseases (liver disease, hematological diseases, infections, malignant neoplasms, pregnancy) that affect the coagulation fibrinolytic parameters.
300
1st name | Ryuta |
Middle name | |
Last name | Nakae |
Nippon Medical School
Department of Emergency and Critical Care Medicine
113-8603
1-1-5, Sendagi, Bunkyo-ku, Tokyo
03-3822-2131
nakae@nms.ac.jp
1st name | Ryuta |
Middle name | |
Last name | Nakae |
Nippon Medical School
Department of Emergency and Critical Care Medicine
113-8603
1-1-5, Sendagi, Bunkyo-ku, Tokyo
03-3822-2131
nakae@nms.ac.jp
Department of Emergency and Critical Care Medicine, Nippon Medical School
KAKENHI
Japanese Governmental office
Institutional Review Board, Nippon Medical School Hospital
1-1-5, Sendagi, Bunkyo-ku, Tokyo
03-3822-2131
03-3822-2131
NO
日本医科大学付属病院 高度救命救急センター、日本医科大学武蔵小杉病院 救命救急センター、日本医科大学多摩永山病院 救命救急センター、日本医科大学千葉北総病院 救命救急センター
2020 | Year | 09 | Month | 21 | Day |
Unpublished
34
Completed
2019 | Year | 08 | Month | 01 | Day |
2019 | Year | 09 | Month | 19 | Day |
2019 | Year | 10 | Month | 01 | Day |
2023 | Year | 03 | Month | 31 | Day |
2020 | Year | 09 | Month | 21 | Day |
2023 | Year | 04 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047778
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |